REGENXBIO Announces Presentations at the Angiogenesis, Exudation, and Degeneration 2023 Conference
/PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced that three presentations on RGX-314 will be presented at the Angiogenesis, Exudation, and...